Gluten sensitivity in patients with primary Sjögren's syndrome

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 8, 2007, Pages 962-967

  Lidén, Maria ^a   Kristjánsson, Gudjón ^a,b   Valtýsdóttir, Sigrídur ^a   Hällgren, Roger ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Reykjavik City Hospital   (Iceland)

Author keywords

Coeliac disease; Gluten sensitivity; Nitrogen oxide; Primary Sj gren's syndrome

Indexed keywords

GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; NITRIC OXIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; FOOD; GASTROINTESTINAL SYMPTOM; HUMAN; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; SELF REPORT; SJOEGREN SYNDROME;

ADULT; AGED; CELIAC DISEASE; FEMALE; GLUTEN; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; SJOGREN-LARSSON SYNDROME;

EID: 34447122619     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701195345     Document Type: Article

References (48)

1. Fox RI. Sjögren's syndrome. Lancet 2005;366:321-31.
2. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164:1275-84.
3. Szodoray P, Barta Z, Lakos G, Szakall S, Zeher M. Coeliac disease in Sjögren's syndrome: a study of 111 Hungarian patients. Rheumatol Int 2004;24:278-82.
4. Collin P, Korpela M, Hallstrom O, Viander M, Keyrilainen O, Maki M. Rheumatic complaints as a presenting symptom in patients with coeliac disease. Scand J Rheumatol 1992;21:20-3.
5. Luft LM, Barr SG, Martin LO, Chan EK, Fritzler MJ. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases. J Rheumatol 2003;30:2613-9.
6. Iltanen S, Collin P, Korpela M, Holm K, Partanen J, Polvi A, et al. Celiac disease and markers of celiac disease latency in patients with primary Sjögren's syndrome. Am J Gastroenterol 1999;94:1042-6.
7. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-42.
8. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346:180-8.
9. Troncone R, Greco L, Mayer M, Paparo F, Caputo N, Micillo M, et al. Latent and potential coeliac disease. Acta Paediatr 1996;Suppl 412:10-4.
10. Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: beyond the gut. Trends Immunol 2004;25:578-82.
11. Hadjivassiliou M, Maki M, Sanders DS, Williamson CA, Grunewald RA, Woodroofe NM, et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 2006;14(66):373-7.
12. Bizzaro N, Villalta D, Tonutti E, Tampoia M, Bassetti D, Tozzoli R. Association of celiac disease with connective tissue diseases and autoimmune diseases of the digestive tract. Autoimmun Rev 2003;2:358-63.
13. Viljamaa M, Kaukinen K, Huhtala H, Kyronpalo S, Rasmussen M, Collin P. Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol 2005;40:437-43.
14. Kerttula TO, Collin P, Polvi A, Korpela M, Partanen J, Maki M. Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alterations in circulating T cell receptor gamma/delta subsets. Arthritis Rheum 1996;39:1733-9.
15. Wucherpfennig KW. Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr Opin Immunol 2001;13:650-6.
16. Freitag T, Schulze-Koops H, Niedobitek G, Melino G, Schuppan D. The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmun Rev 2004;3:13-20.
17. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117:297-303.
18. Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology 2005;128(Suppl 1):S104-8.
19. Sategna Guidetti C, Solerio E, Scaglione N, Aimo G, Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 2001;49:502-5.
20. Dezi R, Niveloni S, Sugai E, Pedreira S, Smecuol E, Vazquez H, et al. Gluten sensitivity in the rectal mucosa of first-degree relatives of celiac disease patients. Am J Gastroenterol 1997;92:1326-30.
21. Troncone R, Greco L, Mayer M, Mazzarella G, Maiuri L, Congia M, et al. In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA. Gastroenterology 1996;111:318-24.
22. Loft DE, Marsh MN, Crowe PT. Rectal gluten challenge and diagnosis of coeliac disease. Lancet 1990;13(336):953.
23. Kristjansson G, Högman M, Venge P, Hällgren R. Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn. Gut 2005;54:769-74.
24. Kristjansson G, Venge P, Wanders A, Lööf L, Hällgren R. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004;53:1806-12.
25. Kristjansson G, Serra J, Lööf L, Venge P, Hällgren R. Kinetics of mucosal granulocyte activation after gluten challenge in coeliac disease. Scand J Gastroenterol 2005;40:662-9.
26. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
27. Grisham MB, Pavlick KP, Laroux FS, Hoffman J, Bharwani S, Wolf RE. Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease. J Invest Med 2002;50:272-83.
28. Forsythe P, Gilchrist M, Kulka M, Befus AD. Mast cells and nitric oxide: control of production, mechanisms of response. Int Immunopharmacol 2001;1:1525-41.
29. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993;48:1034-43.
30. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001;164:1376-81.
31. Holm K, Maki M, Savilahti E, Lipsanen V, Laippala P, Koskimies S. Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet 1992;339:1500-3.
32. Jarvinen TT, Kaukinen K, Laurila K, Kyronpalo S, Rasmussen M, Maki M, et al. Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol 2003;98:1332-7.
33. Salmi TT, Collin P, Jarvinen O, Haimila K, Partanen J, Laurila K, et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther 2006;1(24):541-52.
34. Marsh MN. The natural history of gluten sensitivity: defining, refining and re-defining. Q J Med 1995;88:9-13.
35. Troncone R, Franzese A, Mazzarella G, Paparo F, Auricchio R, Coto I, et al. Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus. Am J Gastroenterol 2003;98:590-5.
36. Niveloni S, Dezi R, Pedreira S, Podesta A, Cabanne A, Vazquez H, et al. Gluten sensitivity in patients with primary biliary cirrhosis. Am J Gastroenterol 1998;93:404-8.
37. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-50.
38. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
39. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30-7.
40. Schuppan D, Esslinger B, Dieterich W. Innate immunity and coeliac disease. Lancet 2003;362:3-4.
41. Tuckova L, Novotna J, Novak P, Flegelova Z, Kveton T, Jelinkova L, et al. Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J Leukoc Biol 2002;71:625-31.
42. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-77.
43. McManus R, Kelleher D. Celiac disease: the villain unmasked? N Engl J Med 2003;348:2573-4.
44. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005;129:1294-301.
45. Farrell RJ. Infant gluten and celiac disease: too early, too late, too much, too many questions. JAMA 2005;293:2410-2.
46. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003;290:1721-8.
47. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005;18(293):2343-51.
48. Wahlberg J, Vaarala O, Ludvigsson J. Dietary risk factors for the emergence of type 1 diabetes-related autoantibodies in 21/2 year-old Swedish children. Br J Nutr 2006;95:603-8.